Price movement over the last 24 hours
Align Technology, Inc. vs United States Natural Gas Fund — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while United States Natural Gas Fund trades at $10.42. The key difference: Align Technology, Inc. is trading nearer its 52-week high, United States Natural Gas Fund nearer its low. Which is the better fit depends on your goals.
| ALGN | UNG | |
|---|---|---|
Market Cap | $12.86B | — |
Sector | Health | Commodities - Energy |
52-Week High | $207.19 | $16.90 |
52-Week Low | $124.88 | $10.15 |
Enterprise Value | $11.92B | — |
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
UNG (United States Natural Gas Fund) trades at $10.60, down 2.12% amid bearish technical signals with 17 sell indicators versus 3 buy signals. The ETF faces headwinds from natural gas price volatility, though RSI levels near 30 suggest potential oversold conditions. Recent news highlights weather-driven demand fluctuations and structural challenges including contango effects that have historically eroded long-term returns.
Outlook remains cautious given the fund's tracking of futures contracts rather than company fundamentals. Key risks include weather dependency and LNG export volatility, while oversold technical conditions may offer short-term trading opportunities for risk-tolerant investors.
Trailing returns across standard periods
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →UNG is a commodity ETF that tracks the daily price movements of natural gas futures. It primarily invests in front-month contracts at the Henry Hub, making it a highly volatile tool for short-term trading rather than long-term holding due to contango and roll costs.
Read more on UNG →